In our study, we did not notice significant changes in glycemic control between diabetic mice treated with MyoAb and the control antibody in the groups not receiving insulin, although some diabetic mice receiving the control antibody group were found deceased, likely due to uncontrolled hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.